Mirum Pharmaceuticals, Inc.
MIRM
$72.00
$0.190.27%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 304.55M | 277.67M | 280.32M | 284.45M | 278.37M |
Total Receivables | 106.84M | 95.85M | 78.29M | 68.53M | 60.43M |
Inventory | 22.94M | 22.42M | 22.40M | 21.59M | 20.44M |
Prepaid Expenses | 19.07M | 14.87M | 11.78M | 12.06M | 8.59M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 453.40M | 410.82M | 392.79M | 386.63M | 367.83M |
|
|||||
Total Current Assets | 453.40M | 410.82M | 392.79M | 386.63M | 367.83M |
Net Property, Plant & Equipment | 10.12M | 8.77M | 9.81M | 10.35M | 9.86M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 237.87M | 243.85M | 249.82M | 255.79M | 261.77M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 7.32M | 5.90M | 5.81M | 5.81M | 4.22M |
Total Assets | 725.83M | 690.25M | 670.75M | 667.89M | 660.75M |
|
|||||
Total Accounts Payable | 17.66M | 11.64M | 14.62M | 9.55M | 9.84M |
Total Accrued Expenses | 72.18M | 64.07M | 72.86M | 64.11M | 54.15M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 2.08M | 1.64M | 1.71M | 1.51M | 1.07M |
Total Finance Division Other Current Liabilities | 52.88M | 50.22M | 37.36M | 40.59M | 47.25M |
Total Other Current Liabilities | 52.88M | 50.22M | 37.36M | 40.59M | 47.25M |
Total Current Liabilities | 144.80M | 127.58M | 126.55M | 115.75M | 112.31M |
|
|||||
Total Current Liabilities | 144.80M | 127.58M | 126.55M | 115.75M | 112.31M |
Long-Term Debt | 308.93M | 308.51M | 308.08M | 307.67M | 307.24M |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 7.88M | 7.00M | 7.97M | 8.48M | 8.24M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 9.05M | 13.90M | 2.51M | 3.97M | 3.97M |
Total Liabilities | 470.67M | 456.99M | 445.11M | 435.87M | 431.77M |
|
|||||
Common Stock & APIC | 919.53M | 892.37M | 870.19M | 851.50M | 835.62M |
Retained Earnings | -664.72M | -658.86M | -644.18M | -620.39M | -606.16M |
Treasury Stock & Other | 352.00K | -258.00K | -373.00K | 920.00K | -477.00K |
Total Common Equity | 255.16M | 233.26M | 225.64M | 232.02M | 228.99M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 255.16M | 233.26M | 225.64M | 232.02M | 228.99M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 255.16M | 233.26M | 225.64M | 232.02M | 228.99M |
|